Page last updated: 2024-08-24

lissamine rhodamine b and Ewing Sarcoma

lissamine rhodamine b has been researched along with Ewing Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beery, E; Fenig, E; Lahav, M; Luria, D; Nordenberg, J; Uziel, O; Yerushalmi, R	1

Other Studies

1 other study(ies) available for lissamine rhodamine b and Ewing Sarcoma

Article	Year
Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro. Experimental oncology, 2007, Volume: 29, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Dyes; Humans; Imatinib Mesylate; In Vitro Techniques; Inhibitory Concentration 50; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Rhodamines; Sarcoma, Ewing	2007

Article

Year

Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro.

Experimental oncology, 2007, Volume: 29, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Dyes; Humans; Imatinib Mesylate; In Vitro Techniques; Inhibitory Concentration 50; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; Rhodamines; Sarcoma, Ewing

2007